These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39095209)

  • 1. Circulating High Mobility Group Box-1 Does Not Predict Pulmonary Arterial Hypertension in Children with Congenital Heart Disease: A Prospective Cohort Study.
    Caracci B; Pehora C; Benson L; Steinberg BE; Goldenberg NM; Taylor K
    J Cardiothorac Vasc Anesth; 2024 Oct; 38(10):2356-2361. PubMed ID: 39095209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum HMGB1 in pulmonary arterial hypertension secondary to congenital heart disease.
    Huang YY; Su W; Zhu ZW; Tang L; Hu XQ; Zhou SH; Fang ZF; Li J
    Vascul Pharmacol; 2016 Oct; 85():66-72. PubMed ID: 27568461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Li Y; Tan XQ; Jia P; Zhao J; Liu D; Wang T; Liu B
    Pediatr Cardiol; 2017 Dec; 38(8):1620-1626. PubMed ID: 28819713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Connective Tissue Growth Factor as a Biomarker of Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Adults.
    Liu W; Hua Y; Zheng D; Lv W; Zhang W; Chen Q; Huang R; Li X
    Circ J; 2023 Mar; 87(4):527-535. PubMed ID: 36843115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between congenital heart disease complicated with pulmonary artery hypertension and circulating endothelial cells as well as endothelin-1.
    Li X; Qiu J; Pan M; Zheng D; Su Y; Wei M; Kong X; Sun W; Zhu J
    Int J Clin Exp Pathol; 2015; 8(9):10743-51. PubMed ID: 26617785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic Evaluation of Children with Persistent or Recurrent Pulmonary Arterial Hypertension Following Complete Repair of Congenital Heart Disease.
    Latus H; Wagner I; Ostermayer S; Kerst G; Kreuder J; Schranz D; Apitz C
    Pediatr Cardiol; 2017 Oct; 38(7):1342-1349. PubMed ID: 28681131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Plasma Connective Tissue Growth Factor Levels in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
    Li G; Tang L; Jia P; Zhao J; Liu D; Liu B
    Pediatr Cardiol; 2016 Apr; 37(4):714-21. PubMed ID: 26714814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.
    Sanli C; Oguz D; Olgunturk R; Tunaoglu FS; Kula S; Pasaoglu H; Gulbahar O; Cevik A
    Pediatr Cardiol; 2012 Dec; 33(8):1323-31. PubMed ID: 22526220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.
    Fang ZF; Huang YY; Tang L; Hu XQ; Shen XQ; Tang JJ; Zhou SH
    Pediatr Cardiol; 2015 Jun; 36(5):1062-9. PubMed ID: 25737007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma copeptin levels in children with pulmonary arterial hypertension associated with congenital heart disease.
    Gaheen R; El Amrousy D; Hodeib H; Elnemr S
    Eur J Pediatr; 2021 Sep; 180(9):2889-2895. PubMed ID: 33813676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiostatic Peptide, Endostatin, Predicts Severity in Pediatric Congenital Heart Disease-Associated Pulmonary Hypertension.
    Daly CM; Griffiths M; Simpson CE; Yang J; Damico RL; Vaidya RD; Williams M; Brandal S; Jone PN; Polsen C; Ivy DD; Austin ED; Nichols WC; Pauciulo MW; Lutz K; Nies MK; Rosenzweig EB; Hirsch R; Yung D; Everett AD
    J Am Heart Assoc; 2021 Oct; 10(20):e021409. PubMed ID: 34622662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood biomarkers and their potential role in pulmonary arterial hypertension associated with congenital heart disease. a systematic review.
    Giannakoulas G; Mouratoglou SA; Gatzoulis MA; Karvounis H
    Int J Cardiol; 2014 Jul; 174(3):618-23. PubMed ID: 24814894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of endothelial biomarkers according to reversibility of pulmonary hypertension secondary to congenital heart disease.
    Smadja DM; Gaussem P; Mauge L; Lacroix R; Gandrille S; Remones V; Peyrard S; Sabatier F; Bonnet D; Lévy M
    Pediatr Cardiol; 2010 Jul; 31(5):657-62. PubMed ID: 20195855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Correlation between endogenous sulfur dioxide and homocysteine in children with pulmonary arterial hypertension associated with congenital heart disease].
    Yang R; Yang Y; Dong X; Wu X; Wei Y
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):625-9. PubMed ID: 25224243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of plasma asymmetric dimethyl-L-arginine levels in detection of pulmonary hypertension in children with CHD.
    Farag M; El Amrousy D; El-Serogy H; Zoair A
    Cardiol Young; 2018 Sep; 28(9):1163-1168. PubMed ID: 29950194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical value of ADMA in patients with pulmonary arterial hypertension combination with congenital heart disease].
    Chen P; Huang Y; Fang Z; Hu X; Shen X; Zhou S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 42(1):35-40. PubMed ID: 28216495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide in pediatric patients with pulmonary arterial hypertension.
    Takatsuki S; Wagner BD; Ivy DD
    Congenit Heart Dis; 2012; 7(3):259-67. PubMed ID: 22325151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry.
    Hill KD; Lim DS; Everett AD; Ivy DD; Moore JD
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):865-73. PubMed ID: 20549685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THE SYSTEM OF SEROTONIN AND ITS METABOLISM IN PLATELETS IN CHILDREN WITH CONGENITAL HEART DEFECTS OF AN EARLY AGE].
    Mindubayeva F; Niyazova Y; Nigmatullina R; Kabiyeva S; Salikhova Y
    Georgian Med News; 2020 Jan; (298):42-46. PubMed ID: 32141846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics.
    Jin N; Yu M; Du X; Wu Z; Zhai C; Pan H; Gu J; Xie B
    BMC Cardiovasc Disord; 2023 Mar; 23(1):167. PubMed ID: 36991345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.